Back to search

Article

Diosmetin blocks type Ⅰ interferon signaling by metabolic control of phosphatidylethanolamine

2023-02-09

Abstract excerpt

<title>Abstract</title> <p>Type I interferon (IFN-I) is essential in the development of Systemic Lupus Erythematosus (SLE) and many other autoimmune diseases. To explore the metabolic regulations of IFN-I signaling pathway, we conducted a high through-put screening of a small molecule library and identified diosmetin as a potent compound for blocking IFN-I signaling. We showed diosmetin functioned by preventing t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b61570f-ced1-56cd-8d96-181eaa2ae021
DOI
10.21203/rs.3.rs-2528258/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Diosmetin blocks type Ⅰ interferon signaling by metabolic control of phosphatidylethanolamineDOI 10.21203/rs.3.rs-2528258/v1
Select a neighboring publication to make it the new centre.